Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism

The Journal of Clinical Endocrinology and Metabolism
Paola SartoratoMaria-Christina Zennaro

Abstract

We have analyzed the human mineralocorticoid receptor (hMR) gene in 14 families with autosomal dominant or sporadic pseudohypoaldosteronism (PHA1), a rare form of mineralocorticoid resistance characterized by neonatal renal salt wasting and failure to thrive. Six heterozygous mutations were detected. Two frameshift mutations in exon 2 (insT1354, del8bp537) and one nonsense mutation in exon 4 (C2157A, Cys645stop) generate truncated proteins due to premature stop codons. Three missense mutations (G633R, Q776R, L979P) differently affect hMR function. The DNA binding domain mutant R633 exhibits reduced maximal transactivation, although its binding characteristics and ED(50) of transactivation are comparable with wild-type hMR. Ligand binding domain mutants R776 and P979 present reduced or absent aldosterone binding, respectively, which is associated with reduced or absent ligand-dependent transactivation capacity. Finally, P979 possesses a transdominant negative effect on wild-type hMR activity, whereas mutations G633R and Q776R probably result in haploinsufficiency in PHA1 patients. We conclude that hMR mutations are a common feature of autosomal dominant PHA1, being found in 70% of our familial cases. Their absence in some famili...Continue Reading

References

Mar 1, 1990·The Journal of Clinical Endocrinology and Metabolism·U KuhnleD Armanini
Nov 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·L J BloemJ H Pratt
Sep 8, 1995·The Journal of Biological Chemistry·M C ZennaroP J Fuller
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Jun 9, 1998·The Journal of Steroid Biochemistry and Molecular Biology·M LudwigF Bidlingmaier
Jun 17, 1998·Molecular Endocrinology·B CouetteM E Rafestin-Oblin
Jun 17, 1998·The EMBO Journal·J FagartM E Rafestin-Oblin
Jan 19, 1999·Molecular Endocrinology·C MassaadR Barouki
Feb 25, 2000·Molecular and Cellular Endocrinology·M Y ZhouE P Gomez-Sanchez
Jul 6, 2000·Trends in Endocrinology and Metabolism : TEM·M Young, J W Funder
Jul 27, 2000·American Journal of Physiology. Endocrinology and Metabolism·P PenfornisM Lombès
Feb 24, 2001·American Journal of Physiology. Renal Physiology·N Farman, M E Rafestin-Oblin
Mar 20, 2001·American Journal of Physiology. Endocrinology and Metabolism·S ViengchareunM Lombès
Jun 28, 2001·Physiological Reviews·A Aranda, A Pascual
Nov 24, 2001·Current Biology : CB·B E BlackB M Paschal
Jun 20, 2002·The Journal of Biological Chemistry·Sheerazed BoulkrounNathalie Courtois-Coutry

❮ Previous
Next ❯

Citations

Sep 28, 2013·Current Hypertension Reports·Qi ZhaoJiang He
May 12, 2004·Molecular and Cellular Endocrinology·P SartoratoM-C Zennaro
Mar 17, 2004·Current Opinion in Pediatrics·V Matti Vehaskari
Nov 6, 2010·Endocrine Reviews·Walter L Miller, Richard J Auchus
Jan 20, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kei KamideToshiyuki Miyata
Apr 7, 2009·Journal of Pediatric Endocrinology & Metabolism : JPEM·Noriko UchidaTetsuo Mori
Sep 22, 2011·Journal of Pediatric Endocrinology & Metabolism : JPEM·Susan M O'ConnellCatherine S Y Choong
Dec 3, 2011·Journal of the American Society of Nephrology : JASN·Jiqiu WangGuang Ning
Dec 4, 2009·Journal of Endocrinological Investigation·F L Fernandes-RosaS R Antonini
Jun 15, 2011·Molecular and Cellular Endocrinology·Maria-Christina ZennaroFábio L Fernandes-Rosa
May 14, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Nourdine Faresse
Mar 30, 2017·The Journal of Endocrinology·Maria-Christina Zennaro, Fabio Fernandes-Rosa
Apr 14, 2006·Journal of the American Society of Nephrology : JASN·David S GellerRichard P Lifton
Dec 17, 2010·The Journal of Clinical Endocrinology and Metabolism·Fábio L Fernandes-RosaMaria-Christina Zennaro
Jun 20, 2019·Physiological Reviews·Jenny van der WijstOlivier Devuyst
Oct 11, 2013·American Journal of Physiology. Renal Physiology·Ganesh PatharePedro San-Cristobal
Aug 15, 2017·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Toshihiro TajimaAkie Nakamura
Dec 17, 2014·Journal of Pediatric Endocrinology & Metabolism : JPEM·Hale Unver TuhanAyhan Abaci
May 3, 2006·Human Molecular Genetics·Leena PeltonenAarno Palotie
Jun 22, 2005·The Journal of Biological Chemistry·Randy K BledsoeShawn P Williams
Jun 5, 2007·Arquivos brasileiros de endocrinologia e metabologia·Fábio L Fernandes-Rosa, Sonir R R Antonini
Oct 27, 2016·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Yoshimi NishizakiKeisuke Nagasaki
May 1, 2007·Expert Review of Endocrinology & Metabolism·Felix G Riepe
Sep 3, 2011·Cardiovascular Therapeutics·Mark Glover, Jenny Clayton
Mar 28, 2012·Hormones : International Journal of Endocrinology and Metabolism·Ioannis D KostakisDespina Perrea
Nov 24, 2021·British Journal of Pharmacology·Claudia GrossmannDiego Alvarez de la Rosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.